BirdDog Technology Limited (BDT) Earnings Call Transcript & Summary
August 29, 2024
Earnings Call Speaker Segments
Unknown Executive
executiveGood morning, everyone, and welcome to BirdDog's FY '24 results webinar. I'm Ben Larsen from NWR Communications. Joining me from the company today is Chief Executive Officer and Managing Director, Dan Miall; as well as Chief Financial Officer, Barry Calnon. [Operator Instructions] We'll do our best to get to all questions asked. Thank you, and over to you, Dan.
Daniel Miall
executiveThanks very much, Ben. And welcome everyone to our presentation today. I'd like to talk about a number of things with the business. But firstly, in case you didn't know, I'm Dan Miall. I'm the CEO of BirdDog here. And next to me is Barry Calnon. He's our CFO. So in today's presentation, we'll be talking about the performance of the business. And I'm sure if anyone's read the announcements this morning, there's a bit to talk about there. But underneath that, there's actually quite a lot of details that we'd like to go through. So I'm going to attempt to be as real as possible in explaining what's been going on and also where the business is heading, because I think it's really -- it's a pivotal part -- a pivotal stage in the business' existence, really. And frankly, at the end of this, hopefully, you'll see that there is actually some excitement about where we're moving forward. I was thinking about when we started out what the best word to describe this last 12 months is, and I think exceptional is probably it, and exceptional in many different ways. Undeniably, from the financial performance, it's been exceptionally poor. That has had a number of underlying reasons as to why that happened, but also underneath that, the exceptional performance that we've done in terms of reshaping the business. And throughout this presentation, I'll talk to you very much about the financial side of things as it is important. We're not trying to distract from that. But also talk about the exceptional work that we have been doing that really lays the path as we move forward. So with this, I'll start with the presentation. So to begin with, we'll talk about the summary of last year. And let's dig straight into the financials. Frankly, financial year 2024 was below what we set out to expect, and that's pretty clear in terms of the performance that we've achieved. That came about or that occurred via a number of different reasons. Some of them were within the company and specific things that we've done, and other ones were certainly outside of our control, things like macroeconomics, and also, to an extent, some industry and market factors. What I'd like to focus on really is the company specific things that have impacted our performance. We have disclosed over the last 12 months some challenges we've had with one of our key suppliers, which did lead into a legal situation that we've had to work through, and also we've been working on a number of new products and some changes within the business. So I guess the best way to describe what happened in the last 12 months is there was a lot of reorganization and a lot of changes that have happened. That reorganization, obviously, happened around building up our new products, but there's also a significant reduction in the operating costs of the business. And you'll see there -- we've spoken about it over time and we've been adding to that -- we've had around about $3 million of operating expenses reduced in the business. That gives us a great footing moving forward in terms of how we can return to profitability. But importantly, we haven't cut into the absolute fabric of the business. We're still able to deliver on the products that we want to deliver and we're still able to function as a business exceptionally well. Getting back to some of the distractions or the issues we've had in the business. That legal issue that we had with our key supplier, that supplier actually represented around about 70% of our business in terms of our camera supply. Now that over the course of the 12 months led to a number of issues. Firstly, we ran down our inventory on those cameras, which meant, frankly, in the second half of the financial year, we had less inventory to sell of the products that people wanted to buy. So that impacted our top line of the business in terms of being able to sell products. Coincidentally, with that, we also had the legal situation that was going on with that. Now that tied up a number -- or it cost quite a significant amount of money in terms of bringing that litigation piece to the business. Now that process went throughout a fair amount of the whole year, and so that was a downward trend in terms of how much the business was spending on a monthly basis. So adding to those additional issues around just general macroeconomics and industry factors, that meant that really we saw a performance that was subpar of what we wanted to. It was really a double down of issues. When you take away some of those extenuating circumstances, the underlying performance of the business in some ways was similar to the year before. Now I've got some good news on that, that we'll talk about later. But from that point of view, there were some extenuating costs there that we've worked through, and I'm pleased to report that we've actually moved through those. So when I talk about the transitional or transformational part of the business, we've really got a lot of that work that we've done in the last year and the costly parts of that behind us. So looking at what we did do in the last 12 months, so on top of the financial side of things, where there's clearly a significant loss that was incurred. As we knew there was going to be some challenges with our key supplier of cameras, we actually embarked on a pretty substantial R&D process. And that was to make sure that as we come out the other side of any situation, that we did have products to sell. If we were sitting here at the end of financial year 2024 and hadn't spent that money and time and effort on the R&D side of things, we wouldn't have products to sell and we wouldn't have a future in terms of how we return to profitability. Now the exciting thing that we've done with this is bring a number of products to market already. Inside 12 months, which is a very short period of time, we brought out 4 products. They started shipping in May of 2024, so right at the back end of that financial year, and immediately started to have an impact on the business. The first thing that I'd like to talk about with those new products is the market acceptance, but also the commercials around that as well. The market acceptance has been very strong, and immediately as we started shipping these products, it had a turnaround effect within the business. And we'll talk a little bit more about the financial side of things shortly, but they've had a dramatic impact in terms of the revenue associated with the business at the top line, but actually, more importantly, the bottom line in terms of the margins that we're able to achieve. I'll get into the products a little later as well. But fundamentally, we've managed to move up the chain in terms of our supply and manufacturing capabilities to deliver twice the margins that we have had in the previous -- in previous years. So that combined with the new products and the demand for those is giving us good scope to feel confident about where we're moving forward. But let's get back to some of the financials. I'm going to move on to Barry to let him talk about the summary of what happened in financial year 2024 and comparatives, and then we'll get on to talking more about some of the structural sides of things with the business.
Barry Calnon
executiveThanks, Dan. Undoubtedly, yes, the headline value of negative $16.9 million after tax is exceptional, if not, frankly, awful. However, let's -- I think it's important to break those components down for the nonrecurring elements of that $16.9 million. Firstly, the noncash impairment losses of $5.1 million, primarily the settlement of the litigation that was commercially agreed in June of 2024 and documented at the back end of July, which is why we announced on the 29th of July. And there was an intangible write down. So we don't have any intangibles on our balance sheet at 30 June. So that was $5.1 million in noncash. And then there was $2.6 million of cash outflows relating to legals and advisory, which is 90% related to the litigation. So that's $7.7 million. So that brings us back to a normalized EBITDA, and actually, coincidentally, a normalized loss after tax of $9 million. Yes, the negative $9 million is exceptional, awful, albeit not quite double the half year loss of $5.3 million before tax, which became $5.9 million after tax, as we do recognize the deferred tax assets at the half year. That not quite doubling was made because of the turnaround that started in the month of May of 2024 with the X1s launching, delivering, shipping and invoicing. That was accelerated in the month of June, and you would have seen that commentary in our foresee at the end of July off the back of the X1 series, both the Standard and the Ultra, which certainly provided us some impetus going into fin '25. In terms of cash, at year-end, it was $16.5 million, which bottomed out after the settlement of litigation at the end of July. The selective buyback in the middle of July and the bulk of the legal expenses paid, that bottomed out just below $12 million. We are now above $12 million and rising. Pleasingly, and Dan touched on this briefly, the $3 million plus of overheads that we saved on an annualized basis in fin '24 are now embedded in fin '25, along with the margins that Dan was talking about, literally double our historical margins on both a gross margin basis and a net margin basis. So the events time line, the next one depicts the business' turnaround and our journey through fin '24 and beyond.
Daniel Miall
executiveThanks, Barry. So I think this slide here is actually quite important because it tells us a story of almost 2 BirdDogs. And I'm actually calling the business BirdDog 2.0 as we move forward. And there's some really strong reasons for this. Frankly, we had an awful period, which was both on the financial side of things, but also in dealing with some of these distractions with the business. And you can see throughout 2023 and into the first quarter at least, if not beyond, of 2024 of our calendar year, we've been working through a number of issues. There was challenging supply chain issues, there was challenging inventory-based issues. Behind the scenes, we've actually been working extremely hard on building out our new product range to make sure that as we come out of that challenging time, we had not only products to sell, but products to sell that were beneficial to our customers and our business. And so really that time line, where the dotted line sits in May, is really the turnaround. It's the tale of 2 stories of BirdDog. From here on in, we've addressed some of the core issues. We've addressed the litigation piece with our previous supplier, and we can move on. We've also started delivering these new products. And as Barry and I've mentioned as well, the margins are an important part of this in the fact that they're double the previous margins. In addition to this, one of the biggest stories, I think, that we need to talk about is how we've been communicating these products to market and why they've been successful. In the past and what's pretty normal in our industry is products get announced at a trade show or some kind of event where people can learn about what's coming up, and then sometime in the future, they get released. Over the last full 12 months, we've been working on changing that entirely. So we've not announced products at all until they're ready to go. And these X1 products, which were announced and shipped in May, are really the first example of that. And that means 2 things. One is that we're delivering on what we've been working on and able to recognize that from both a business point of view, but also a revenue point of view immediately. And it also means that we're building out a reputation in terms of what we're delivering, then can actually, yes, build into the stability of the business. So in terms of products that we've released, we're not even quite halfway through our next generation of product releases, and we've already seen great news in terms of how we've turned around this business. If you look at on a monthly basis, we were in negatives over $500,000. And come May, that started to turn around. In June, we've turned that into a black number. We've turned that into a positive NPAT and also EBITDA. That's as we've released these X1 and Maki products. Now I'm really pleased. And I'm looking at one of these cameras at the moment. But last week, we not only announced, but began shipping globally the X5 camera. So that's now delivering more revenue to the business. That's really exciting, again, because we've been able to triple down on that structure of how we're announcing products. Now from here, we've got a trail of good news moving forward, that is next month we have a trade show in Amsterdam called IBC. We're again announcing and shipping a product there. And you'll see a pattern emerge over the next few months through October, November and December of new products being announced and shipping. And the good thing with this is all of these fall in line with our next-generation BirdDog 2.0 in terms of the margin and in terms of that -- living out our announcement and delivery. And that actually flows over to how we're talking about our news to you in terms of disclosures to stock markets as well. We'll be less talking about future opportunities and where we're planning on going, and we're talking more about what we've actually delivered and how we've been working through that. So I'm pleased in some way with this presentation to be able to start talking about that. And like I said, that's not to discount the fact that it was an incredibly distracting and expensive year in the last 12 months. So as we move into financial year 2025, there's actually some pretty significant things that have changed. One of the biggest risks and the costly part of last year was actually to do with supply concentration. We've been working diligently around that in terms of bringing up new suppliers. We now have a diversification not only by suppliers or manufacturing partners, but also by countries as well. Those of you who have listened to our presentations before will have heard us talk about GSA accreditation. We had a project we are working on to start manufacturing our products in Canada. Now that actually got derailed temporarily because of the situation around supply chain. But during the process of bringing these new products to market, we have actually managed to bring one of our products, this brand new X5, to market in a GSA-friendly manufacturing place. Now what that allows us to do is go into government purchases in the USA and other areas around the world and have preferred access to contracts because they're manufactured in a GSA or a general services agreement friendly country. We'll be working with our other products and our manufacturing partners to extend out our range that is GSA friendly as well. So this is something that we've been working on in addition to bringing these products to market. Now we've mentioned a number of times the settlement and completion of the dispute with our prior contract manufacturer. That's now behind us. That's very much last year. It was a very challenging and also, as I've mentioned a number of times, a very costly exercise. But it allows us now to move forward with confidence with our new products and without any of those distractions. We've had some really encouraging launches, and I've mentioned a couple of times about these products. But I can't emphasize enough how successful these new product launches have been in terms of the acceptance by our customers but also the quality of these releases. As part of building these products to market, we've ensured that our quality assurance systems are as high as possible. And we're seeing a much reduced rate in terms of DOA or failed products in the field. Now as an interesting statistic, we sold around about 4x as many products over the last few months, the equivalent products last year in terms of our previous corresponding period, and we saw a 20x less in terms of the amount of units that have been returned with any kind of failure. So we're not only meeting, we're absolutely beating industry norms in terms of that reliability of these new products. All of this is building towards building better reputation, building better awareness and ultimately, better market share for us as we move forward. So we're really excited about what that means as we move forward. Probably one of the biggest changes that we're looking at moving forward is actually the ability to focus back on the business. Undeniably, last year, again, being a very challenging year from a commercial but also from a financial sense and also a litigation sense was quite distracting. And so from that point of view, as we've now settled all of these previous issues that we've been dealing with and also have our new products coming into market, we're able to focus on our job at hand, which is ultimately to make this business successful. When you water it down, our job is to design innovative game-changing products, bring them to market and commercialize them and sell them ultimately to make a profit. That's what we're focusing on as we move forward, and we're really excited about where we're at now as we do move forward, back to basics, if you like. Here's a bit of a view of our products, which is really just a slide showing some of the new generation. The one thing that I think is important to talk about with our new products is you won't find any camera or any product that looks like ours. And I mentioned briefly earlier that we've moved up the supply chain. One of those benefits is that we've increased our margins. And that's obviously helping us return and give confidence around returning to profitability in the long term. What it also means is that we've built these products to be in spec and to be used for our customers. Too many companies out there actually take products from other manufacturers and put their brand on there or put their badge on and try and sell them. What we've done is actually look at our customers' requirements and build those from the ground up. So we have embedded IP and embedded value in all of our next-generation products beyond what we've had in the past. So we're taking this opportunity with building these new products to make sure that we have a recognizable brand, functions, and also doubling down on that innovative approach. One of the big things that we have that is an advantage compared to our competitors is we have an ecosystem. We have not only cameras -- now, cameras do represent a big chunk of our business, but we also have converters, we have software, and we have cloud platforms as well. And this is something that's really important to us as we move forward, because it allows us to have a solution for our customers. We're not about trying to sell a black box or trying to make a product that's slightly cheaper than somebody else. We're building solutions. Now as we've rebuffed and strengthened our product portfolio moving forward, we're now able to really double down on that in terms of our solutions. And I'm going to jump ahead a little bit in here in terms of our priority and talk about Remedi. Remedi is our medical solution that we've developed. We've been talking about this for a little over 12 months. And Remedi has had -- the last 12 months has been really a defining period for it, where we've had some seed installations that have gone into it that have now turned into reference sites. Remedi is -- in last financial year didn't produce a huge amount of revenue for the business, but it has now got the potential and is now building out that order pipeline and also our overall project pipeline, not only in Australia, where it's our core market for Remedi, but now increasingly in the USA. So what we're really excited about with Remedi is that will give us incremental business revenue to the business, and it's also a recurring revenue-based model. So whilst this has taken some time, partially to do with the distractions we've had in the business, we are still seeing that on track in terms of the market awareness and now the uptake of that as well. So we look forward to what that looks like as we move forward. In addition to this, I mentioned that a trade show that's coming up next month. We've got a product announcement in terms of cameras. We also have some real fundamental shift change in the way our software works on our cloud platform as well. This lays the boundaries for -- or lays the platform as we move forward next year in terms of how we're going to double down on that cloud and recurring revenue in our core markets as well. So I guess looking at what we've achieved over the last 12 months and what happened in the last 12 months, undoubtedly, it was a highly challenging market. We did have some dramatic headwinds in terms of that litigation piece, which was extremely expensive to the business. We also had some challenges around supply in terms of being able to deliver products that were applicable to customers, which was a downward pressure on revenue. We had elevated R&D to bring these next-generation products to market. But at the same time, we've also reorganized the business. We've taken a significant amount of money out of the cost of the business to give us a much more applicable run rate, I suppose, in terms of how we can actually make the business profitable and then bringing these new products to market with double the margin, and increased reliability and increased features gives us a much more confident footing as we move forward. So for us, looking at last year, we've -- it is a transformational year. It was an expensive year, but it was a one-off year in a lot of those. We've sealed off and completed all of those challenging parts, and we're now looking forward to how we can move forward with these new products and moving forward with success. So at this point, that's the end of the presentation. Now I'm happy to take any questions. Barry, did you have anything else to add at this point or should we move to Q&A?
Barry Calnon
executiveI think Q&A. And yes, maybe we'll go back to the time line because I think that's a powerful...
Daniel Miall
executiveYes.
Unknown Executive
executiveAll right. Thank you, Dan and Barry. Yes, a few questions did come through. So we'll kick off with our first one here. So in your June quarterly foresee, you talked about EBITDA positive in the month of June. This person is looking to understand -- there was another question on this as well, actually. So together. So they're looking to understand how the business has performed in the first 2 months of FY '25, i.e., as the trend continued.
Daniel Miall
executiveYes. So we're not quite finished in the second month, but we've got a pretty good indication. So basically, for us at this stage, we're really excited to see that trajectory is continuing on. So whilst we were in the black in June, we're also seeing that same thing happen in July. And then now in August as well, we're confident that that's also going to close out with a positivity in EBITDA.
Barry Calnon
executiveOn the EBITDA level and, pleasingly, with the revenues, with only half of the new -- the next-generation cameras through.
Daniel Miall
executiveAbsolutely, Barry. So a good point is that we are only halfway through delivering our new generation products, and we're already able to achieve in these last 3 months now of positivity. So it's heading in the right direction.
Unknown Executive
executiveNext question, can you be more specific on the double -- doubling the margins based on historical comments? Is that gross margin -- i.e., has that specifically manifested in the P&L?
Barry Calnon
executiveSure. So the eagle eyes would have noticed that in fin '23, our margin was 21.4%, at the bottom net margin line, 21.4%. That became 20.3% in the fin '24 year, again, another challenging macroeconomic environment in industry, markets, et cetera. So that's the base of our historical margins. Our gross margins are double, have achieved through the months of June, July and August -- not withstanding we've got 1 more trading -- 1.5 more trading days of shipments to go, but our gross margins are in the 50s and our net margins are in the low 40%. So 20.3% that we achieved in fin '24. We have seen 3 consecutive months, June, July and August, with a net margin above 40%. Which is why we're saying double the margins at both the gross and the net margin line.
Unknown Executive
executiveNext question, is the litigation consigned to history? Also, how are you progressing with selling the finished goods you received as part of the settlement?
Daniel Miall
executiveYes. So I'm pleased to say the litigation is consigned to history. It was becoming a -- I think it was becoming apparent to me that the actual cost of litigation was going to become greater than the argument that we had with the litigation. So we had to look at how we closed that out, and that's what we did. So that is now being closed. It's finalized. And we have no further requirements within that moving forward. So for us, we're able to completely focus moving forward. So that's absolutely consigned to history. In terms of part of that settlement, you would have seen in a previous announcement that we did actually have some finished products that the previous manufacturer had finished, and we've taken possession of those. Now at this stage, I'm pleased we've only had possession of that for a month. I think it's less than a month or just on a month.
Barry Calnon
executiveThree weeks, yes.
Daniel Miall
executiveAnd we've already sold more than 20% of those. We've already moved more than 20% in terms of value out of the business. So that's encouraging. We fully intend and are working very quickly to make sure that all of that inventory is finished within this financial year. And as you can see, with that statement, we're well ahead of that schedule at this point. So we'll keep chipping away at that and making sure that we move them on. We've got no interest in having aged inventory of the old products. But we are able to move them on while still maintaining margins on the new products and profitability.
Unknown Executive
executiveWhat will be new for the business at IBC in a couple of weeks time?
Daniel Miall
executiveSo it's actually a funny situation we're in, because we no longer release products based on trade shows. What we have is a nice set of circumstances, where, as I was mentioning before, we announce a product when it's ready to ship. We actually have a product that's ready to go at IBC. So coincidentally, we'll be doing that. That's another camera. It's one that fits very much in what we consider to be the quantity place within our product portfolio. And again, it's full of some really innovative features. Now in line with announcing things before they're ready to go, I'm not going to give too much away other than it's an accretive model within the portfolio. We're not adding another one that's going to compete with existing products in the market from our offerings. And we think, again, it's got some really innovative features. So we're really excited to announce that. In addition, we've got a game-changing cloud-based solution, which allows us to dramatically reduce the cost of running cloud-based video production. One of the, I guess, dirty little secrets of cloud-based video production is the cost associated with either getting the video into the cloud in the first place or processing that with high costs around your cloud service provider, whether that's AWS or Google Cloud or any of the other ones. We've broken some new technology here that allows us to really dramatically reduce those costs. So we'll be announcing that and showing that at IBC as well.
Unknown Executive
executiveJust a request for further detail on the 4 separate contract manufacturers for the new-gen cameras. Where are they producing? Does this open up U.S. GSA accreditation? And what's the percentage split between the 4?
Daniel Miall
executiveYes. So at the moment, our manufacturing is all done in East Asia. So we have a lot of our manufacturing -- the current products that we have in market are split between China and Taiwan. So the Taiwan product is GSA compliant. Because it's made in Taiwan, it means that we're able to apply for GSA, TAA compliance as well. That allows us to sell in many different countries, into governments where there may be some sensitivities. In terms of the other products that are built in China, at the moment, we're working with those manufacturers to be able to move that -- or to make that manufacturing portable to be able to manufacture these products as additional requirements are needed in other countries as well. So for the moment, we have one product that is GSA applicable. And then the other products are made in China at the moment, but they are made under our designs and under our observation, I suppose. So we're able to move that to different jurisdictions as we need to.
Unknown Executive
executiveSo further questions on the next-gen cameras. So they deliver 2x margins, is quite a dramatic increase. Where is this coming from? And does this imply expected gross margins of greater than 50% for FY '25?
Daniel Miall
executiveSo I can talk about where they come from, and then maybe if you want to talk about the expected margins. What's actually happened here, I've briefly touched on it. But it's actually a really important point, is these products don't look like any other products. The previous generation of cameras that we had and actually a lot of cameras out there, all look really -- well, they will look similar to other ones. And that's because you have this concept of an OEM that's making the original product and then there's a re-badged or rebranded version of that. Now for us, we went a lot deeper than that with our previous generation products, where we put our own chips inside to make the product do more than what the original one did. But it remains the fact that there was already a finished product that we then turned into something that was ours. With these new generation products, we've actually moved up that manufacturing chain, where these products are designed by us, for us, and ultimately for our customers. And that means that we're not taking fundamentally a finished product and remarketing it. We're building this product from scratch, which means that we get the benefits of that specification that we can actually increase those margins because this is being built for us. There's not a double amount of revenue required in terms of profitability for people in the chain.
Barry Calnon
executiveAnd to round out that -- the second half of that question, Ben. So I think it was around gross margins and above 50%. I was talking about net margins in the 40s, and also confirming through June, July and August, our gross margins on our next-gen cameras will be north of 50%. Now we will be reporting the back end of the -- the balance of the former contract manufacturer and that finished goods that we took possession of in the first week of August. We will be reporting that separately from a gross margin perspective, so that it doesn't impact any of our current sales. But yes, our gross margins for next-generation camera is north of 50%.
Unknown Executive
executiveYou did talk about inventory earlier, but we had some questions around it. So inventory target is still 2 to 3 months with the new generation. Does this include inventory deposits? What's the targeted inventory balance?
Daniel Miall
executiveSo in terms of the manufacturing time, the benefit we've got here -- and it's something I hadn't actually spoken about too much -- is we've got a brand-new product portfolio with these new cameras. We don't have any mid-life products or products that are using older technology. All of our products are using brand-new technology. But also it's given us the opportunity to make sure that, that supply chain is able to be able to work with what we need to do with manufacturing. The result of that is that the build time or the lead time to build these products is much shorter than we've experienced in the past. So that creates a bit of room for us in terms of being able to optimize the amount of stock that we hold on hand so that we don't need to have as much. We have been running that down for various reasons over the last 12 months. But Barry, if you want to talk a little bit about just the...
Barry Calnon
executiveYes, sure. So 60 to 90 days remains our target hold. And in terms of trade, so to speak, North Asia and East Asia haven't changed the way that they conduct their business, which is 30% down, 70% before it leaves their factory. But yes, we are -- we remain targeting 60 to 90 with a view of bringing that to 60 to 75 days given the shorter lead times that we're now experiencing, particularly across that geographical diversification of our contract manufacturers.
Unknown Executive
executiveA question about R&D. When is it expected to slow down? And what's the expected figure for FY '25?
Daniel Miall
executiveSo R&D is an interesting one, because as a technology business, we need to invest in R&D. Otherwise, we are just a trading company. And the reality is we plan on growing the business, we plan on growing the opportunities we have, which means we do need to invest in R&D. Now bringing out a whole portfolio of cameras in 1 year has elevated that. There's a lot of costs associated with, like I mentioned before, making these cameras work and look and feel a BirdDog camera. We have to do all the tooling and all the moldings and everything, which are elevated costs. Now those won't be apparent year-on-year-on-year. We are able to get the benefit of these for a number of years. So in terms of core R&D, I expect that to start to reduce as we get the final -- a lot of these portfolio of products out. Then we go back to more business as usual. So in terms of reducing R&D, we have a reduction in terms of the hard costs with bringing these products to market. In terms of core capabilities, though, we're still very much back to the fact that we need R&D within the business to continue to be profitable in the long term.
Barry Calnon
executiveYes. And $5.5 million that we invested in R&D in fin '24 against the $3.8 million in fin '23 is probably the -- where that question has manifested from. We expect it to be about the same for R&D. The budget is in that $5.5 million again for fin '25. And then we'll see where the product road map takes us.
Unknown Executive
executiveRegarding the cash backing of $12.3 million at 28th August, is this an expected low point? Is the rebuild of working capital complete and legal settlements done? And is there any -- are there any plans for further buybacks, the share price below cash NTA?
Barry Calnon
executiveUnderstood, Ben. So what -- during our presentation, I mentioned that the low point at the end of July was in the 11s. It's now back north of 12. And we expect that to continue to grow. The second part of that question -- and just remind me if I've missed one of the elements of that, please, Ben -- was buybacks. But the -- we completed a buyback exactly 6 weeks ago tomorrow. Yes, it was a selective buyback. Our on-market buyback finished in December of 2023, yes, because we spent $650,000 in fin '24 on that. It's on the Board's agenda. We don't see in the foreseeable future that being something that the Board has strong appetite for. But of course, it will be something that we'll continue to consider, the Board will continue to consider.
Unknown Executive
executiveSo another question here. What are the actions being taken for recovery in the EU and U.K. markets? Were distributor relationships impacted?
Daniel Miall
executiveThat's a great question, actually. We've had a challenge, which we've spoken about a number of times through various reports and presentations, is Europe has been impacted more heavily in terms of the overall market performance than what we've seen in the U.S. and other areas. We've taken quite a lot of steps in terms of how we approach the market in Europe, where previously we had effectively a master distributor that was representing us for the whole of Europe, including the U.K. What we've now done is gone far more nuanced and focused. So U.K. is a very important part of the European business that we have as a whole. Included in Europe, we also have Germany. France and Spain are the other major markets that we're working in. So rather than just having an umbrella that's working a master distributor for the whole region, we now have direct relationships in these areas. That's actually now seeing dramatic impacts. Germany, for example, is outperforming what we've ever seen as we bring out these new products. We're seeing that acceleration happening in Spain, and we've got some exciting news happening in France as well. The big, I guess, point here is we don't plan on going too broad and having 100 distributors for every country in Europe, but there's key markets that we need much more focus on. And that's what we've been redrawing and defining over the last 12 months as well. And we're now seeing the benefits of that coincidentally with these new products that are coming to market. So Europe has been a problem in terms of its revenue compared to historical, but we are seeing that, that's now starting to claw back. And certainly, with having the focus in each of these individual markets is giving us much more visibility of how we can move those levers to make sure that we're getting the most out of those markets for our revenue, but also for, importantly, market share.
Unknown Executive
executiveWhat is the expected sales and marketing for FY '25? Can you provide a bit more color on the overall cost base versus FY '24?
Barry Calnon
executiveYes. So sales and marketing will be very similar in fin '25 against fin '24, Ben. We'll be doing things slightly differently. And Dan has alluded to some exciting news coming out of France and Spain, and some of that exciting news will almost certainly be launched -- or, sorry, promoted at IBC rather than right here right now. Again, trying to live our new mantra of delivering and then telling, yes.
Daniel Miall
executiveBut in terms of our approach to market, we have some events in industries where we do need to promote ourselves and work with. We're very much looking at making sure that we build that awareness over the next 12 months. That doesn't look like it's a more expensive process than last year. It's somewhere in line, about the same in terms of sales and marketing.
Unknown Executive
executiveSo $1.7 million in trade creditors at June '24, which was an increase on FY '23. What does this relate to?
Barry Calnon
executiveFrankly -- and I did touch on it in my slide around the fin '24. It was the back end of the litigation costs that were paid in July. And that's why we peaked below 12 at the end of July and we're now back above 12 at 12.3.
Unknown Executive
executiveAnd how are overall sales of new products progressing this quarter?
Daniel Miall
executiveSo this quarter, we're actually seeing a number of things. Firstly, we had our product announcements and starting to ship in May. In June, we actually didn't have a product announcement, but we've still managed to report, as I mentioned earlier with that previous question, a profitable -- sorry, June and July, I should talk about. July was profitable even without a new product. So that sort of shows the underlying demand is building for those products that are in market. In terms of sales, we've got ongoing orders for our new products and also our converters and various other products in the mix. But we've also got orders for these new generation of products that are in the books as well. So we've got visibility and confidence that as we move forward with these new product announcements, that we'll also have continued revenue. So at this stage, the sales is looking much better than we've had in the past, and that obviously with the higher margins gives us confidence that the profitability will begin to build as well.
Unknown Executive
executiveAll right. Thank you, Dan and Barry and everyone for sending their questions through. That's it for questions today. Should you have any follow-up questions, please send them through by e-mail or -- time to get back to you. I'll now pass it back to Dan for closing comments.
Daniel Miall
executiveThanks very much, Ben. And actually, I really do appreciate the interactivity with more questions this time. We do understand that last year was a particularly expensive and costly year for everybody involved, particularly the business, but, obviously, everyone that's involved with that business. We took every step we could to make sure that was addressed as expediently as possible. And we are really proud of how we've managed to turn around in a relatively short time into something that is some better news. We're very serious about how BirdDog 2.0 looks. We're here with new products in the market. We've got that margin that's been increased, and we're seeing that continue with these new products that we're continuing to announce as well. It gives us confidence. We're just talking about the sales, the invoices that we've already put out there in terms of sales revenue, but also the orders we have, upcoming products with our core partners that have been disclosed about what's coming up. We're seeing some benefits now starting to roll through with the work that we've done on the medical side of things with Remedi, with our seed and our reference sites now being used to start to close larger projects. That pipeline is now building pretty strongly. And ultimately, at the end of this, whilst last year was one that we'd rather not repeat and we're not planning on repeating, we do enter this new financial year still very well funded and we're generating revenue now, again we're generating profits. So for us, we are very much looking forward to next year rather than looking backwards on what last year was, given the fact that we've closed out all of these major headwinds. So we thank everyone for being supportive of the business. We know it has been a challenging time. And there's been some questions raised about what we've been up to. Hopefully, through this presentation and now that we're able to report on the beginnings of what's happening moving forward, that gives you some confidence that actually what we've been working on over the last 12 months has transformed the business into something that is pretty exciting moving forward. But thank you again for the support, but also thank you for listening to us in this presentation. And if you have any further questions, please feel free to reach out.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete BirdDog Technology Limited transcript — plus 256,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to BirdDog Technology Limited earnings transcripts and 256,000+ others is available through the
EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in BirdDog Technology Limited or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.